| HOME >> BIOLOGY >> TECHNOLOGY |
________ ________ ________ ________
Unaudited US GAAP results for the three months and six months to June 30,
2008
Consolidated Statements of Cash Flows
3 months 3 months 6 months 6 months
to June to June to June to June
30, 30, 30, 30,
2008 2007 2008 2007
$M $M $M $M
________ ________ ________ ________
CASH FLOWS FROM OPERATING
ACTIVITIES:
Net (loss)/income (79.0) (1,811.3) 49.6 (1,698.6)
Adjustments to reconcile net
(loss)/income to net cash provided
by operating activities:
Depreciation and amortization 48.9 33.5 96.3 63.7
Amortization of deferred financing
charges 1.2 9.2 2.5 9.2
Interest on building financing
obligation 0.7 - 1.9 -
Share based compensation 19.4 11.8 35.7 22.4
In-process R&D charge on New River
acquisition - 1,896.0 - 1,896.0
Impairment of intangible assets 90.4 - 90.4 -
Gain on sale of long-term assets (0.4) - (9.8) -
Gain on sale of product rights (9.1) (5.0) (16.7) (4.9)
Movement in deferred taxes (16.4) 0.1 17.4 13.8
Equity in losses/(earnings) of
equity method investees 1.9 (0.7) 0.3 (1.2)
Changes in operating assets and
liabilities, n
'/>"/>
| SOURCE Shire Ltd Copyright©2008 PR Newswire. All rights reserved |